TP53 and hematologic disorder: Non-Invasive Genomic Risk Assessment (NIRCA) [260] and Functional Analysis of Separated Alleles in Yeast (FASAY) [261] are two additional techniques used in the diagnosis of TP53 and p53 mutations in hematologic malignancies.